Table of Contents
<< Previous Issue | Oct 2004 (Vol: 2004, Issue: 52) | Next Issue >> |
- Section: Business Commentaries
-
Royalty Rates - What is There to Hide?
- Section: Company Profile
-
NicOx SA
- Section: Deal Trackers
-
Ampligen (polyI:polyC12U)
- Section: Distribution & Marketing
-
New Distributor for Cedax® in the US
- Section: General
-
MGI Pharma’s US$122 M Oncology Spree
- Section: Licensing
-
Transition Licenses Diabetes Regenerative Therapy to Novo Nordisk
-
Pfizer Licenses Nitric Oxide-Donating Compounds from NicOx
- Section: Mergers & Acquisitions
-
Mylan to Acquire King for US$4 B
-
Pfizer Sells Two of its Generics Units
- Section: Research & Development
-
Biogen Idec and Sunesis Sign Small Molecule Cancer Agreement